- Research article
- Open Access
Ketone body β-hydroxybutyrate ameliorates colitis by promoting M2 macrophage polarization through the STAT6-dependent signaling pathway
BMC Medicine volume 20, Article number: 148 (2022)
Ketone body β-hydroxybutyrate (BHB) has received more and more attentions, because it possesses a lot of beneficial, life-preserving effects in the fields of clinical science and medicine. However, the role of BHB in intestinal inflammation has not yet been investigated.
Colonic mucosa of inflammatory bowel disease (IBD) patients and healthy controls were collected for evaluation of BHB level. Besides, the therapeutic effect of exogenous BHB in a murine model of acute dextran sulfate sodium (DSS)-induced colitis were assessed by body weight change, colon length, disease activity index, and histopathological sections. The regulatory effectors of BHB were analyzed by RT-qPCR, immunofluorescence, and microbe analysis in vivo. Moreover, the molecular mechanism of BHB was further verified in bone marrow-derived macrophages (BMDMs).
In this study, significantly reduced BHB levels were found in the colonic mucosa from IBD patients and correlated with IBD activity index. In addition, we demonstrated that the administration of exogenous BHB alleviated the severity of acute experimental colitis, which was characterized by less weight loss, disease activity index, colon shortening, and histology scores, as well as decreased crypt loss and epithelium damage. Furthermore, BHB resulted in significantly increased colonic expression of M2 macrophage-associated genes, including IL-4Ra, IL-10, arginase 1 (Arg-1), and chitinase-like protein 3, following DSS exposure, suggesting an increased M2 macrophage skewing in vivo. Moreover, an in vitro experiment revealed that the addition of BHB directly promoted STAT6 phosphorylation and M2 macrophage-specific gene expression in IL-4-stimulated macrophages. Besides, we found that BHB obviously increased M2 macrophage-induced mucosal repair through promoting intestinal epithelial proliferation. However, the enhancement effect of BHB on M2 macrophage-induced mucosal repair and anti-inflammation was completely inhibited by the STAT6 inhibitor AS1517499.
In summary, we show that BHB promotes M2 macrophage polarization through the STAT6-dependent signaling pathway, which contributes to the resolution of intestinal inflammation and the repair of damaged intestinal tissues. Our finding suggests that exogenous BHB supplement may be a useful therapeutic approach for IBD treatment.
Inflammatory bowel diseases (IBD), including ulcerative colitis (UC) and Crohn’s disease (CD), are emerging as chronic relapsing inflammatory conditions in gastrointestinal tract, which are characterized by impaired intestinal barrier integrity and disorder of immune response with excessive pro-inflammatory cells infiltration while less generation of anti-inflammatory cells [1,2,3]. Signaling crosstalk between intestinal epithelial cells and immune cells deeply implicated in intestinal micro-environment homeostasis of IBD, among which macrophages are one of the most abundant cells in the intestine and closely involved in the pathogenesis of IBD .
Macrophages, as a core element of the innate immune systems, eliminate invading pathogen and can alter the polarization into pro-inflammatory (M1) and anti-inflammatory (M2) phenotypes dependent on the micro-environment [5,6,7]. As reported, M1 macrophages are elicited by lipopolysaccharide (LPS) and interferon-γ (IFN-γ) to promote Th1 immunity and produce pro-inflammatory cytokines for host defense against infection [8,9,10,11]. M2 macrophages are induced by IL-4 and IL-13 to modulate tissue remodeling, wound healing, and immune modulation through the IL-4 receptor alpha chain (IL-4Ra) [12,13,14]. Abnormal macrophage polarization occurs during the development of IBD, which has been recently targeted as a potential therapeutic strategy for IBD [4, 15, 16]. Macrophage polarization is regulated by various transcriptional factors. STAT1 mediates M1 activation, whereas STAT6 is responsible for M2 polarization . However, how M2 macrophage polarization is fine-tuned by STAT6 is still incompletely clear.
The endogenous ketone metabolites refer to three kinds of small, water-soluble and lipid-derived molecules, consisting of acetoacetate, beta-hydroxybutyrate (BHB), and acetone [18,19,20]. Ketogenic enzymes, including acetyl-CoA-acetyltransferase-1 (ACAT1), 3-hydroxy-3-methylglutaryl-CoA-synthase-2 (HMGCS2), HMG-CoA lyase (HMGCL), and 3-hydroxybutyrate dehydrogenase-1 (BDH1), were highly expressed in the intestinal epithelium of healthy individuals . Hence the ketone metabolic molecules are also largely produced in the gut of mammals during fatty acids oxidation metabolic program in time of nutrient deprivation, prolonged fasting, and exercise . Accumulating evidence suggested that the most prominent ketone metabolite, β-hydroxybutyrate (BHB), possesses a lot of beneficial effects in the field of clinical science and medicine [22,23,24]. Previous studies reported that BHB presents the anti-aging effects during caloric restriction or fasting, which was generally considered to be beneficial to stem cell maintenance and tissue regeneration [18, 25, 26]. Recent studies also indicated that BHB can serve as important and instructive immune cell effectors through inhibiting Nlrp3 inflammasome activation and regulating intestinal pro-inflammatory Th17 cells [27,28,29,30]. However, whether BHB regulates M2 macrophage polarization in the intestine, inflammation, and IBD has remained elusive.
In this study, we explored the effects of BHB on human and experimentally induced IBD and elucidated the important roles of BHB in the pathogenesis of IBD. Here, we report that BHB levels are significantly decreased in the colonic mucosa from IBD patients and dextran sulfate sodium (DSS)-challenged mice. Importantly, the administration of exogenous BHB alleviates the severity of DSS-induced colitis. Moreover, BHB promotes M2 macrophage polarization through enhancing STAT6 phosphorylation induced by IL-4. Furthermore, we investigated the clinical significance of BHB in IBD patients and found that the levels of BHB in the colonic mucosa are negatively associated with the IBD activity index and the erythrocyte sedimentation rate (ESR) values in patients with IBD, which might offer an insight into the pathogenesis of IBD.
Antibodies and reagents
Anti-HMGCS2 (ab137043), anti-p-STAT6 (ab263947), anti-STAT6 (ab217998), and anti-p-JAK2 antibodies (ab92552) were obtained from Abcam. Anti-JAK2 antibody (3230T) was purchased from Cell Signaling Technology. Anti-ACAT1 (16215-1-AP) and anti-BDH1 (15417-1-AP) were purchased from Proteintech. Anti-ZO-1 (GB111981), anti-Occludin (GB111401), anti-F4/80 (GB113373), anti-Brdu (GB12051), and anti-PCNA (GB12010) were purchased from Servicebio.
Dextran sulfate sodium (DSS) was obtained from MP Biomedicals. Recombinant mouse GM-CSF (96-315-03-20) and recombinant mouse IL-4 (96-214-14-20) were obtained from Peprotech. BHB (S1031) and AS1517499 (S8685) were purchased from Selleck.cn. Cell Counting Kit-8 (CCK8) was obtained from Dojindo Laboratories, Japan. Clodronate liposomes (40337ES08) were obtained from Yeasen. Lipopolysaccharides (297-473-0), BHB sodium (13613-65-5), vancomycin (1404-93-9), neomycin-sulfate (1405-10-3), metronidazole (443-48-1), and ampicillin (69-52-3) were obtained from Sigma-Aldrich. BHB Colorimetric Assay Kit (700190) was obtained from Cayman Chemical. BCA Protein Assay Kit (P0012S) were obtained from Beyotime Biotechnology. Gentle Cell Disassociation Reagent (07174), DMEM/F12 with 15 mM HEPES (36254), and IntestiCult organoid growth medium (06005) were purchased from StemCell Technologies. Matrigel (356231) was purchased from Corning.
Endoscopic colonic mucosal biopsy samples were collected from IBD patients and non-IBD healthy donors attending the Department of Gastroenterology, Nanfang Hospital. All diagnoses and clinical disease activity assessments were based on a standard combination of clinical, endoscopic, histological, and radiologic criteria. All intestinal pinch biopsies were collected from consenting individuals during routine endoscopy according to the protocols approved by the Ethics Committee of Nanfang Hospital of Southern Medical University. Demographic characteristics are shown in Additional file 1: Table S2.
Beta-hydroxybutyrate (BHB) measurements
Each colonic mucosal sample from human and murine model was split in two for total protein measurement and BHB measurement respectively. Samples were freshly washed by PBS and collected by centrifugation (centrifuged at 300×g for 5 min). Total proteins were measured by BCA Protein Assay Kit. BHB level was determined by BHB Colorimetric Assay Kit. Level of mucosal BHB was normalized to total protein of each sample.
All animal research protocols were approved by the Institutional Animal Care and Use Committee of Southern Medical University (K2019032), which are in full compliance with the fundamental principles of replacement, reduction, and refinement in animal research. Wild type (WT) 8- to 10-week-old male C57BL/6 J mice (weighing 20–23 g) were obtained from Cyagen Biosciences and maintained under specific pathogen-free (SPF) condition in accredited animal facilities at Southern Medical University. Briefly, all mice were housed in a room with controlled temperature (21–23 °C) and lighting (12/12-h light-dark cycle) and were free access to water and food. Before samples collection, mice were anesthetized with an intraperitoneal injection of ketamine-medetomidine and euthanized by cervical dislocation. All efforts were made to minimize the suffering and discomfort experienced by the animals.
Mice model of DSS-induced colitis and regeneration was established according to a published procedure . Briefly, mice were administered with water containing 2.5% DSS for 5 consecutive days, and then followed by 6 days normal drinking water, which was defined as regeneration after colitis. During experiment, body weight and disease activity index of mice were monitored every day. The scores of disease activity index (DAI) were evaluated according to the standard criteria provided by a published procedure . The animals were included in the study according to the body weight change and DAI during DSS treatment. The animals were excluded if prematurely died preventing harvest of biological samples. The mice were sacrificed and colon tissues were collected for various analyses. Besides, histological scores of mice were assessed by two pathologists in a double-blind manner.
For exogenous BHB intervention, BHB enemas were prepared by using BHB sodium dissolved in saline. Mice were randomly divided into four groups (n = 7 to 10 per group): saline group, BHB group, saline DSS group, and BHB DSS group. Then mice were rectally administered with a single dose of BHB sodium solution (at the concentration of 15 mg/25 g) or saline as a control per day.
For intestinal macrophage depletion, mice were randomly divided into two groups (n = 7 to 8 per group): the saline DSS + clodronate group and the BHB DSS + clodronate group. Then, mice were intraperitoneally injected with clodronate liposomes (4 ml/kg) 5 days prior to DSS treatment and on days 2, 4, and 6 after the start of DSS treatment.
To remove intestinal microbiota, mice were randomly divided into two groups (n = 5 per group): the saline DSS + ABX group and the BHB DSS + ABX group. Then mice were intragastrically administered with antibiotics, including 100 mg/kg vancomycin, 200 mg/kg neomycin sulfate, 200 mg/kg metronidazole, and 200 mg/kg ampicillin, once a day for 5 days prior to DSS treatment.
To inhibit STAT6 phosphorylation in vivo, mice were randomly divided into two groups (n = 6 per group): saline DSS + AS group and BHB DSS + AS group. Then, mice were intraperitoneally injected with 5 mg/kg AS1517499 on days 1, 3, 5, 7, and 9 after the start of DSS treatment.
Histochemistry and immunostaining
Colonic samples from people and mice were fixed in 4% paraformaldehyde for 24 h, embedded in paraffin, and 5-μm-thick sections were used for hematoxylin-eosin (H&E) or immunostaining. For immunohistochemistry and immunofluorescence staining, deparaffinized sections were performed quenching of endogenous peroxidase activity, antigen-retrieval, and subsequent blocking procedures. Slices were incubated in the primary antibodies at 4 °C overnight, followed by incubation with biotinylated secondary antibody for 2 h at room temperature. Protein expression levels were analyzed and scored by professional pathologists with Image-Pro Plus software.
Isolation and culture of bone marrow-derived macrophages
Bone marrow-derived macrophages (BMDMs) were differentiated from bone marrow cells (BM cells) harvested from thighbone and shinbone from 8- to 10-week-old male WT mice. BM cells were cultured at 37 °C in 5% CO2 in Dulbecco's Modified Eagle Medium supplemented with 20% FBS, 100 U/mL penicillin, 100 μg/mL streptomycin, and 30 ng/ml GM-CSF-conditioned medium for 7 days to differentiate to BMDMs. Media were supplemented every 2 days. Non-adherent cells were removed by washing with PBS. After 7 days, the resultant adherent cells were harvested that consisted of > 95% F4/80+ macrophages.
For inflammatory macrophage differentiation, BMDMs were stimulated with 100 ng/mL LPS for 24 h. To generate anti-inflammatory macrophages, BMDMs were stimulated with 100 ng/mL recombinant IL-4 for 48 h. In LPS plus BHB group, BMDMs were treated with 100 ng/mL LPS and 5 mM BHB (S1031, selleck.cn) together for 24 h. In IL-4 plus BHB group, BMDMs were treated with 100 ng/mL IL-4 and 5 mM BHB together for 48 h. In rescue experiments, BMDMs were stimulated with 100 ng/mL IL-4, and then treated with 5 mM BHB or 100 nM AS1517499 alone or together for 48 h.
Real-time PCR was performed as previously described . The mRNA levels of target genes were normalized to that of GAPDH. The primers used for the target genes are shown in Additional file 1: Table S3.
Western blot analysis was performed as previously described . GAPDH was used as an endogenous control. Anti-p-JAK2, anti-JAK2, anti-p-STAT6, and anti-STAT6 were diluted 1:1000. Anti-GAPDH was diluted 1:2000. Secondary antibodies were diluted 1:4000. The ImageJ software was used to quantify and analyze the density of the protein bands.
RNA sequencing was used to measure the mRNA expression levels of many cytokines in IL-4-stimulated BMDMs with or without BHB.
Cell proliferation was measured using a cell counting kit-8 (CCK-8) according to the manufacturer’s instruction. Briefly, 90 μl of IEC-6 cells were plated at a concentration of 2000 cells/well in 96-well plates. CCK-8 working buffer (10 μl) was added into the cultures and incubated at 37 °C for 1 h. Colorimetric measurements were performed at 450 nm on a microplate reader.
Mouse colon organoid culture
Mouse colon organoid was isolated and cultured according to the manufacturer's instruction. Briefly, the colons were obtained and luminal contents were flushed away by using cold PBS. The colons were then transferred to a biosafety cabinet and cut into 2–5 mm pieces. Colon pieces were further digested using the Gentle Cell Disassociation Reagent (StemCell Technologies) on a rocking platform for 20 min. The supernatant was removed and colon pieces were resuspended in cold PBS with 0.1% BSA. The new supernatant was then passed through a 70 -μm strainer and centrifuged at 4 °C 290×g for 5 min to obtain crypts. Isolated crypts were then resuspended in DMEM/F12 with 15 mM HEPES (StemCell Technologies) and counted under a microscope. An equal volume of IntestiCult Organoid Growth Medium (StemCell Technologies) and Matrigel (Corning) were mixed and the suspension was transferred into a pre-warmed 24-well-plate to form domes in the middle of each well. Complete IntestiCult Organoid Growth Medium was added above the domes, and crypts were cultured at 37 °C and 5% CO2. In addition, BMDMs were co-cultured with colon organoid in a transwell system with a 0.4-μm porous membrane that allows extracellular cytokines derived from the BMDMs to contact the organoids directly. Suppression of STAT6 phosphorylation was performed by treatment with 100 nM AS1517499 for 48 h in IL-4-stimulated BMDMs before co-culture.
After 9 days in culture, all organoid numbers and budding organoids were manually counted in each well under light microscope to evaluate growth efficiency. For size measurement, four non-overlapping pictures of organoids in each well were captured under microscope. The surface area of organoid horizontal cross sections was then analyzed by using image-pro-plus software.
Unless otherwise indicated, statistical analyses were performed using the GraphPad Prism software. Except as otherwise indicated, all experimental data are presented as the mean ± SEM, and statistical significance was determined using a two-tailed Student’s t test. P-values < 0.05 were considered significant.
BHB generation are decreased in the colonic mucosa from active IBD patients
Given the evident significance of ketogenic enzyme in ketogenesis, we first analyzed the expression levels of genes encoding ketogenic enzymes in public datasets of IBD samples and found that the mRNA levels of ACAT1, HMGCS2, and BDH1 were significantly decreased in the colonic mucosa from active IBD patients compared to healthy controls, while there was not significant difference in the mRNA level of HMGCL . Consistently, we found that the protein levels of ACAT1, HMGCS2, and BDH1 were significantly reduced in the colonic mucosa from active IBD patients compared to healthy controls (Fig. 1a, b). In addition, DSS mice had decreased expression of ACAT1, HMGCS2, and BDH1 in the colonic tissues (Additional file 1: Fig. S1a-c). These findings suggest that IBD patients may have reduced endogenous ketone metabolites in the colon.
Since BHB is the most prominent ketone metabolite, we subsequently detected the level of BHB by β-Hydroxybutyrate colorimetric assay kit and found that the level of BHB was significantly decreased in the colonic mucosa from active IBD patients compared to healthy controls (Fig. 1c). Furthermore, we explored the clinical impact of BHB in IBD patients and found that colonic BHB levels were negatively correlated with the IBD activity index (Mayo scores in the UC and CDAI in the CD) and ESR values (Fig. 1d). Taken together, these results suggest that decreased BHB production in the colon might be involved in the pathogenesis of IBD.
Exogenous BHB supplement attenuates DSS-induced colitis
To assess whether BHB participates into experimental colitis, we first conducted a study on the colonic level of BHB in mice challenged with 2.5% DSS in drinking water. BHB levels were markedly decreased in the colonic tissues after 6-day DSS treatment (Fig. S1d). This result suggests that BHB may be involved in the development of colitis.
To further confirm the role of BHB in DSS-induced colitis, we next rectally injected exogenous BHB or saline as a control to DSS-exposed mice, according to the methods shown in Fig. 2a. BHB-treated mice showed significantly reduced weight loss, disease activity index, and colon shortening, compared to control mice (Fig. 2b–e). Moreover, histological examination displayed less crypt loss, epithelium damage, and decreased inflammation in the colons of BHB-treated mice than in those of control mice (Figs. 1g and 2f). However, without DSS exposure, BHB administration had no effect on body weight, colonic length, and histology (Fig. 2b, e, g). These results indicate that BHB protects mice from DSS-induced colitis may through inhibiting colonic inflammation and promoting post-injury repair of colonic tissues.
BHB exerts protective effect against colitis dependently via colonic macrophages
Since intestinal epithelial barrier, gut microbiota, and macrophages are critical for the pathological processes associated IBD, we investigated whether the beneficial effect of BHB on colitis is dependent on these factors. First, we examined whether BHB affects intestinal epithelial integrity by measuring the levels of immunofluorescence staining of tight junction proteins ZO-1 and occluding. No difference was noted in ZO-1 and occluding immunostaining between BHB-treated and control groups (Additional file 1: Fig. S2a-d).
The 16S diversity analysis showed that there was no significant difference in alpha diversity between the two groups of mice (Additional file 1: Fig. S3a-b). However, the relative abundance of specific strains, such as Firmicutes at the phylum level and Lachnospiraceae at the family level, was significantly increased in the BHB group when compared to that in the saline group (Additional file 1: Fig. S3c-e); unweighted PCoA analysis revealed that clusters of gut microbiota between BHB and saline mice were entirely separated, suggesting that the gut flora exhibited a very different composition in two groups (Additional file 1: Fig. S3d).
Therefore, we explored whether BHB intervention attenuates DSS-induced colitis is dependent on gut microbiota. To this end, mice were treated with antibiotics (ABX) to ablate the impact of intestinal microbiota followed by rectally injecting exogenous BHB or saline as a control to DSS-exposed mice (Additional file 1: Fig. S4a). After ABX treatment, the mice received BHB enema still developed decreased colitis as reflected by less body weight loss, disease activity index, and colon shortening, as well as significantly reduced histology scores, compared to control mice (Additional file 1: Fig. S4b-g). These results indicate that BHB ameliorates DSS-induced colitis independently of intestinal microbiota.
Subsequently, we asked whether intestinal macrophages are involved in the protective effect of BHB during colitis development. To test it, mice were intraperitoneally injected with clodronate liposomes to accomplish macrophage depletion (Fig. 3a, b). Notably, ablation of macrophage largely abrogated the protective effect of BHB, which failed to improve the clinical parameters of DSS-induced colitis such as body weight loss, disease activity index, and colon shortening (Fig. 3c–f). Histological examination further demonstrated that the beneficial effect of BHB was largely diminished when deletion of intestinal macrophage (Fig. 3g, h). These results show that the protective effect of BHB against DSS-induced colitis is depend on intestinal macrophages.
The protective effect of BHB against colitis involves M2 macrophage polarization
A previous study reported that BHB reduces neuroinflammation through shaping microglia, a group of ramified brain-resident phagocytes, toward anti-inflammatory M2 polarization . Thus, we proposed that BHB administration attenuates DSS-induced colitis may through regulating M2 macrophage polarization in the intestine. As expected, BHB administration resulted in significantly increased mRNA expression of M2 macrophage-associated genes including IL-4Ra, IL-10, arginase 1 (Arg-1), and chitinase-like protein 3 (Chil3), and their downstream effectors, such as FGF2, FGF7, TGFb, TGFbr1, PDGFra, and PDGFrb in the colons of DSS-exposed mice (Fig. 4a, b). Moreover, BHB significantly increased in the number of F4/80+CD206+ M2 macrophages in the colons of DSS-exposed mice as determined by immunofluorescence staining (Fig. 4c, d). Taken together, these results indicate that BHB protects mice from DSS-induced colitis through enhancing M2 macrophage polarization.
BHB promotes IL-4-induced M2 macrophage polarization through the JAK2-STAT6 signaling pathway
To confirm the function of BHB on the induction of M2 macrophage polarization, BHB was added to bone marrow-derived macrophages (BMDMs) isolated from mice in vitro. In agreement with the in vivo data, the addition of BHB significantly increased the mRNA expression of M2-associated genes, including Arg-1, IL-10, Chil3, and Retnla, in IL-4-stimulated BMDMs, but not in BMDMs (Fig. 5a). However, BHB addition did not affect the mRNA expression of M1-associated genes, such as NOS2, TNF-α, IL-6, and IL12p40, in BMDMs, nor in LPS-stimulated BMDMs (Fig. 5b). These results show that BHB promotes IL-4-induced M2 macrophage polarization.
To further dissect the underlying mechanism, BMDMs isolated from mice were stimulated with IL-4 alone or with IL-4 plus BHB, and the mRNA expression profiles were analyzed by RNA sequencing. We observed that a large number of genes, including M2 macrophage-specific genes Arg-1, Chil3, and Retnla, were upregulated in the IL-4 plus BHB group compared to the IL-4 group (Fig. 5c, d). With Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis, it was found that these upregulated genes were significantly enriched in regulation of the JAK-STAT signaling pathway (Fig. 5e). Moreover, protein–protein interaction network analysis of these upregulated genes identified Janus kinase 2 (JAK2) as a downstream signaling molecule of IL-4Ra (Fig. 5f). Binding of IL-4 to IL-4Rα results in tyrosine phosphorylation and activation of STAT6, which is a key signaling node for M2 macrophage polarization [36, 37]. Our findings combined with previous findings suggest that BHB promotes M2 macrophage polarization may through the JAK2-STAT6 signaling pathway.
We next performed western blot analysis to examine whether BHB influences the activation of the JAK2-STAT6 signaling pathway in BMDMs. STAT6 phosphorylation was undetected in unstimulated BMDMs or in stimulated cells with BHB alone. As expected, obvious STAT6 phosphorylation was observed in IL-4-stimulatedBMDMs (Fig. 6a). The addition of BHB increased the intensity of phosphorylated STAT6, but not total STAT6, in IL-4-stimulated BMDMs (Fig. 6a). This result was further confirmed by a significant increase in pSTAT6 when normalized to total STAT6 (Fig. 6b). Consistently, IL-4 and BHB together resulted in significantly increased JAK2 phosphorylation, but both alone cannot in BMDMs (Fig. 6a, b). Collectively, these results indicate that BHB enhances IL-4-induced activation of the JAK2-STAT6 signaling pathway in BMDMs.
We subsequently examined whether the upregulation effect of BHB on IL-4-induced M2 macrophage polarization is dependent on the JAK2-STAT6 signaling pathway. To this end, AS1517499 (AS), a potent STAT6 phosphorylation inhibitor, was administrated in IL-4-stimulated BMDMs with or without BHB, and the mRNA expression of M2-associated genes was measured by real-time PCR. We found that AS treatment effectively suppressed STAT6 phosphorylation in IL-4-stimulated BMDMs (Fig. 6c, d). Moreover, the upregulation effect of BHB on IL-4-induced STAT6 phosphorylation was obviously inhibited by AS (Fig. 6c, d). Consistently, BHB significantly increased the mRNA levels of Arg-1, IL-10, Chil3, and Retnla in IL-4-stimulated BMDMs, but this upregulation role was completely inhibited by AS (Fig. 6e). Taken together, these results show that BHB could directly promote IL-4-induced M2 macrophage polarization through enhancing the JAK2-STAT6 signaling pathway.
The protective effect of BHB against colitis is dependent on STAT6 activation
Because STAT6 activation is a critical signaling node for BHB’s regulating M2 macrophage polarization, we speculated that it is also required for BHB therapeutic role during colitis development. To test it, BHB enema or saline as a control was rectally injected to DSS-exposed mice, then these mice were received intraperitoneal injection of AS1517499 (Additional file 1: Fig. S5a). The mice received BHB treatment displayed increased p-STAT6 phosphorylation in F4/80+ macrophages compared to control mice (Additional file 1: Fig. S6a and c), which was effectively inhibited by AS administration in vivo (Additional file 1: Fig. S6b and d). Consistently, AS administration largely eliminated the protective effect of BHB against DSS-induced colitis as reflected by no significant difference in weight loss, disease activity index, colon shortening, and histology scores between the BHB and saline groups (Additional file 1: Fig. S5b-g). These results indicate that the protective effect of BHB against DSS-induced colitis is dependent on the STAT6 signaling pathway.
BHB-treated M2 macrophages promote intestinal epithelial regeneration
Previous studies have shown that M2 macrophage contributes to tissue repair and regeneration [38, 39]. In this study, we found that BHB treatment promotes intestinal epithelial proliferation during colitis development (Fig. 7a, b). Therefore, we evaluated whether BHB regulates M2 macrophage function in intestinal epithelial proliferation. To test it, BMDMs isolated from mice were stimulated with IL-4 alone or with IL-4 and BHB together to induce M2 macrophage polarization. Then, the cell culture supernatant purified by ultrafiltration was used to stimulate the normal intestinal epithelial cell line IEC-6 and cell proliferation was measured by CCK-8 assays. We found that the levels of cell proliferation were significantly higher in the IL-4 plus BHB group than in the IL-4 group (Fig. 7c). However, this effect was completely inhibited by AS1517499 (Fig. 7c).
To mimic the in vivo environment and investigate the effect of BHB-treated M2 macrophages on intestinal epithelium proliferation, mouse colonic crypts were isolated and cultured in vitro. Then, we co-cultured these colonic organoids with IL-4-stimulated BMDMs with or without BHB in a transwell system, which allows extracellular cytokines derived from the BMDMs to contact the organoids directly. We found that organoids grew without gross abnormalities in the presence of IL-4. Moreover, the number of colonic organoids were significantly higher in the IL-4 plus BHB group than in the IL-4 group (Fig. 7d, e). Moreover, in the IL-4 plus BHB group, organoids were larger in size and show higher percentage of buddings than that in the IL-4 group (Fig. 7f–h). However, these effects were obviously inhibited by AS1517499 (Fig. 7d–h). Taken together, these results indicate that BHB-treated M2 macrophages promote intestinal epithelial cells proliferation and organoids growth through the STAT6-dependent signaling pathway.
Ketone body BHB is generally considered as source of energy for tissues during periods of low-energy states or dietary deprived of carbohydrates . BHB has received more and more attentions, because it possesses a lot of beneficial, life-preserving effects in the fields of clinical science and medicine. However, the role of BHB in intestinal inflammation has not yet been investigated. We herein demonstrate that BHB alleviates intestinal inflammation in DSS-induced colitis, which could be due to its ability to promote M2 macrophage polarization. Furthermore, we demonstrate that locally BHB levels are negatively correlated with the severity of DSS-induced colitis and human IBD.
M2 macrophage polarization has been proposed to play important roles in IBD [15, 41]. Activated macrophages with M2 phenotype results in increased resistant to DSS-induced colitis , while adoptive transfer of in vitro-derived M2 macrophages reduces colonic inflammation in mice . In addition, patients with active CD have reduced numbers of M2-like macrophages, whereas patients with inactive CD have increased numbers of these cells . Therefore, we hypothesized that BHB may regulate M2 macrophage skewing in DSS-exposed colons. Indeed, we found that BHB treatment lead to significantly increased expression of M2-associated genes in DSS-exposed colons, suggesting locally increased M2 macrophage responses. Moreover, we found that BHB was able to directly promote M2 macrophage polarization in vitro, as the addition of BHB markedly increased the expression of M2-associated genes in IL-4-stimulated BMDMs, as well as the phosphorylation of STAT6, which is crucial for M2 macrophage polarization . A previous study showed that macrophage polarization through IL-4 can occur in joint inflammation . It is also possible that BHB could switch M1 macrophages into M2 macrophages in the presence of IL-4 in colonic inflammation, whereas whether this is indeed the case needs to be further investigated.
Although we found that BHB increased STAT6 phosphorylation in IL-4-stimulated BMDMs, BHB alone did not activate STAT6 in BMDMs, suggesting that BHB synergistically enhances IL-4-induced STAT6 phosphorylation and subsequent M2 polarization. Furthermore, we found that BHB increased JAK2 phosphorylation in the presence of IL-4. Binding of IL-4 to IL-4Rα results in signal transduction through JAK2 and phosphorylation of STAT6 . These findings indicate that BHB promotes macrophage M2 polarization through facilitating the JAK2/STAT6 signaling pathway. Protein lysine acetylation is a dynamic process, in which an acetyl group is transferred to a specific lysine by an acetyltransferase like CBP, p300, and PCAF . A recent study has demonstrated that STAT6 acetylated by CBP negatively modulates macrophage M2 polarization . It is possible that BHB promotes macrophage M2 polarization through downregulating CBP-mediated STAT6 acetylation. However, the exact molecular mechanism remains to be further studied.
In this study, we show that BHB facilitates mucosal repair through promoting intestinal epithelial proliferation in murine IBD. Using the DSS-induced colitis model that mimics the clinical pathology of IBD, we found that BHB-treated mice had less crypt loss and epithelium damage in the DSS-exposed colons. Furthermore, we found that BHB increased the expression of bromodeoxyuridine (Brdu) and proliferating cell nuclear antigen (PCNA), two cell proliferation markers, in the DSS-exposed colons. Because M2 macrophages accelerate tissue repair , we speculated that BHB promotes intestinal epithelial proliferation via regulating M2 macrophages. Indeed, we found that BHB-treated M2 macrophages effectively promoted the proliferation of IEC-6 and colonic organoids, but the improvement was significantly inhibited by the STAT6 inhibitor AS1517499.
M2 macrophages are frequently termed “wound healing” macrophages as they produce factors that are important for tissue repair . Clearly, M2 macrophages produce TGFb, Arg-1, and Wnt ligands, which are known to be involved in cell proliferation and tissue repair [41, 46]. TGFb enhances fibroblast proliferation and collagen production observed in macrophage/fibroblast co-cultures . Arginine metabolism by Arg-1 produces polyamines, which are important for cell proliferation . Macrophage Wnt7b contributes to kidney repair through stimulating epithelial responses . Here, we found that BHB significantly increased the expression of Arg-1, TGFb2, TGFb3, Wnt5a, and Wnt10b in IL-4-stimulated BMDMs, among which Arg-1 is the most upregulated gene (Additional file 1: Table S1). This finding suggests that the enhancement effect of BHB on intestinal epithelial proliferation could be largely attributed to BHB’s upregulating Arg-1in M2 macrophages.
There are various exogenous ketone supplements, containing BHB salt, BHB ester, medium chain triglycerides or their combinations [23, 49, 50]. Many studies have linked BHB with intestinal homeostasis. A previous research has shown that exogenous BHB supplement exerts anti-aging effect on intestinal stem cells by reducing oxidative stress-induced DNA damage accumulation . The other study has reported that exogenous BHB supplement alters intestinal stem cell numbers and notch activity to regulate intestinal tissue remodeling . Though these researchers have no direct proof that BHB was found in intestinal lumen, exogenous BHB was believed to actually function in the intestinal tract. In a separate study, BHB content was found in the media of mouse intestinal organoid cultures, which suggests that intestinal-derived BHB could be secreted out of cells . More importantly, the recent research has reported that host production of ketone bodies in intestinal lumen could directly induce microbiota shifts . These discoveries provided very important context to our enema experiments. In the present study, we use BHB salt, the most commonly used and effective exogenous ketone supplement, as supplement intervention to treat DSS-induced colitis. To make sure the supplement intervention could accurately and directly impact on intestine of DSS model, BHB salt was given through therapeutic enema. Recent studies indicate BHB monoester could serve as a salt-free precursor to quickly and accurately raise ketone concentration which provides a more safe and healthy application for BHB supplement [29, 49]. Thus, the effect of BHB monoester on DSS-induced colitis merits further studies.
Prior research indicated that ketogenic states, induced by ketogenic diet or fasting, effectively drive BHB generation both in liver and intestine. Increased crypt BHB level and intestinal stem cells (ISCs) numbers and function was observed in mice fed with ketogenic diet. Notably, HMGCS2-derived BHB in ISCs enhances Notch signaling pathway through suppress activity of class I histone deacetylase (Class I HDAC). The Notch transcriptional program in ISCs dynamically modulates ISC self-renewal and intestinal post-injury regeneration in response to diverse physiological states. These results demonstrated convincingly that intestinal BHB serve as a vital signaling molecule to promote intestinal tissue repair processes through maintaining intestinal stemness . Interestingly, another recent study has provided new evidences for the potential role of ketone in intestinal inflammation through the regulation of gut microbiota and intestinal pro-inflammatory Th17 cells. Ketogenic diet exposure significantly altered gut microbial community structure, which was characterized by notably decreased Bifidobacterium. Further experiment proved that BHB, generated during ketogenic diet, directly inhibit growth of bifidobacterial, which thereby impact immune responses through regulating intestinal Th17 cells populations. These observations together suggested that gut microbial mediated immunomodulation as a mechanism underlying the anti-inflammatory effect of BHB . Increased Th17 immune responses are associated with many autoimmune diseases, including IBD. Th17 cells activation could aggravate intestinal inflammation through expressing IL-17 together with other pro-inflammatory cytokines. Besides, intestinal stemness is essential for tissue remodeling following colitis development. These prominent studies proposed other possibilities that gut microbiota, immune cells, and intestinal stemness modulated by BHB might also contribute to the beneficial effect of BHB on experimental colitis.
In the present study, we showed that BHB promotes M2 macrophage polarization through the STAT6-dependent signaling pathway, which contributes to the resolution of intestinal inflammation and the repair of damaged intestinal tissues. Based on our finding, a hypothesis for the role of BHB in the pathogenesis of IBD is proposed (Additional file 1: Fig. S7), in which decreased epithelium-derived BHB reduces M2 macrophage polarization, resulting in the decline of tissue repair and anti-inflammatory effect, whereas exogenous BHB supplement reinforces the two effects through enhancing M2 macrophage polarization. Thus, exogenous BHB supplement may offer a useful therapeutic approach for IBD treatment.
Availability of data and materials
The data sets supporting the conclusions of this article are listed as follow: https://www.proteinatlas.org; https://platform.opentargets.org. The raw metagenome sequencing data of 16S rDNA reported in this paper have been deposited in the Sequence Read Archive database with the accession numbers: PRJNA812633. The raw metagenome sequencing data of RNA-seq reported in this paper have been deposited in the Genome Sequence Archive database with the accession numbers: CRA006352.
Acetyl coenzyme A acetyltransferase 1
Ketone body β-hydroxybutyrate
Bone marrow-derived macrophages
Cell Counting Kit-8
Chitinase-3-like protein 1
Dextran sulfate sodium
Erythrocyte sedimentation rate
Fibroblast growth factor 2
Fibroblast growth factor 7
3- Hydroxy-3-methylglutaryl-coenzyme A synthase 2
Inflammatory bowel disease
Intestinal epithelial cells
IL-4 receptor α
Integrated optical density
Intestinal stem cells
NOD-like receptor protein 3
Nitric oxide synthase 2
Proliferating cell nuclear antigen
Platelet-derived growth factor receptor α
Platelet-derived growth factor receptor β
Signal Transducer and Activator of Transcription
Transforming growth factor-β
Tumor necrosis factor α
Kaplan GG, Windsor JW. The four epidemiological stages in the global evolution of inflammatory bowel disease. Nat Rev Gastroenterol Hepatol. 2021;18(1):56–66.
Annese V. Genetics and epigenetics of IBD. Pharmacol Res. 2020;159:104892.
Xavier RJ, Podolsky DK. Unravelling the pathogenesis of inflammatory bowel disease. Nature. 2007;448(7152):427–34.
Lin Y, Yang X, Yue W, Xu X, Li B, Zou L, et al. Chemerin aggravates DSS-induced colitis by suppressing M2 macrophage polarization. Cell Mol Immunol. 2014;11(4):355–66.
Na YR, Stakenborg M, Seok SH, Matteoli G. Macrophages in intestinal inflammation and resolution: a potential therapeutic target in IBD. Nat Rev Gastroenterol Hepatol. 2019;16(9):531–43.
Mowat AM, Bain CC. Mucosal macrophages in intestinal homeostasis and inflammation. J Innate Immun. 2011;3(6):550–64.
Bar-On L, Zigmond E, Jung S. Management of gut inflammation through the manipulation of intestinal dendritic cells and macrophages? Semin Immunol. 2011;23(1):58–64.
Zhang Y, Li X, Luo Z, Ma L, Zhu S, Wang Z, et al. ECM1 is an essential factor for the determination of M1 macrophage polarization in IBD in response to LPS stimulation. Proc Natl Acad Sci U S A. 2020;117(6):3083–92.
Lissner D, Schumann M, Batra A, Kredel LI, Kuhl AA, Erben U, et al. Monocyte and M1 macrophage-induced barrier defect contributes to chronic intestinal inflammation in IBD. Inflamm Bowel Dis. 2015;21(6):1297–305.
McAlindon ME, Galvin A, McKaig B, Gray T, Sewell HF, Mahida YR. Investigation of the expression of IL-1beta converting enzyme and apoptosis in normal and inflammatory bowel disease (IBD) mucosal macrophages. Clin Exp Immunol. 1999;116(2):251–7.
Ai L, Ren Y, Zhu M, Lu S, Qian Y, Chen Z, et al. Synbindin restrains proinflammatory macrophage activation against microbiota and mucosal inflammation during colitis. Gut. 2021;70(12):2261–72.
Deng F, Yan J, Lu J, Luo M, Xia P, Liu S, et al. M2 Macrophage-derived exosomal miR-590-3p attenuates DSS-induced mucosal damage and promotes epithelial repair via the LATS1/YAP/ beta-catenin signalling axis. J Crohns Colitis. 2021;15(4):665–77.
Koelink PJ, Bloemendaal FM, Li B, Westera L, Vogels EWM, van Roest M, et al. Anti-TNF therapy in IBD exerts its therapeutic effect through macrophage IL-10 signalling. Gut. 2020;69(6):1053–63.
Maasfeh L, Hartlova A, Isaksson S, Sundin J, Mavroudis G, Savolainen O, et al. Impaired luminal control of intestinal macrophage maturation in patients with ulcerative colitis during remission. Cell Mol Gastroenterol Hepatol. 2021;12(4):1415–32.
Zhou X, Li W, Wang S, Zhang P, Wang Q, Xiao J, et al. YAP aggravates inflammatory bowel disease by regulating M1/M2 macrophage polarization and gut microbial homeostasis. Cell Rep. 2019;27(4):1176–89.e5.
Steinbach EC, Plevy SE. The role of macrophages and dendritic cells in the initiation of inflammation in IBD. Inflamm Bowel Dis. 2014;20(1):166–75.
Su S, Zhao Q, He C, Huang D, Liu J, Chen F, et al. miR-142-5p and miR-130a-3p are regulated by IL-4 and IL-13 and control profibrogenic macrophage program. Nat Commun. 2015;6:8523.
Cheng CW, Biton M, Haber AL, Gunduz N, Eng G, Gaynor LT, et al. Ketone body signaling mediates intestinal stem cell homeostasis and adaptation to diet. Cell. 2019;178(5):1115–31 e15.
Nosadini R, Avogaro A, Doria A, Fioretto P, Trevisan R, Morocutti A. Ketone body metabolism: a physiological and clinical overview. Diabetes Metab Rev. 1989;5(3):299–319.
Fukao T, Lopaschuk GD, Mitchell GA. Pathways and control of ketone body metabolism: on the fringe of lipid biochemistry. Prostaglandins Leukot Essent Fatty Acids. 2004;70(3):243–51.
The Human Protein Atlas. Available from: https://www.proteinatlas.org. Accessed 16 Oct 2018.
Zhang SJ, Li ZH, Zhang YD, Chen J, Li Y, Wu FQ, et al. Ketone body 3-hydroxybutyrate ameliorates atherosclerosis via receptor Gpr109a-mediated calcium influx. Adv Sci (Weinh). 2021;8(9):2003410.
Abbasi J. Ketone body supplementation-a potential new approach for heart disease. JAMA. 2021. https://doi.org/10.1001/jama.2021.8789.
Moller N. Ketone body, 3-hydroxybutyrate: minor metabolite - major medical manifestations. J Clin Endocrinol Metab. 2020;105(9):2884–92.
Veech RL, Bradshaw PC, Clarke K, Curtis W, Pawlosky R, King MT. Ketone bodies mimic the life span extending properties of caloric restriction. IUBMB Life. 2017;69(5):305–14.
Sengupta S, Peterson TR, Laplante M, Oh S, Sabatini DM. mTORC1 controls fasting-induced ketogenesis and its modulation by ageing. Nature. 2010;468(7327):1100–4.
Ang QY, Alexander M, Newman JC, Tian Y, Cai J, Upadhyay V, et al. Ketogenic diets alter the gut microbiome resulting in decreased intestinal Th17 cells. Cell. 2020;181(6):1263–75.e16.
Youm YH, Nguyen KY, Grant RW, Goldberg EL, Bodogai M, Kim D, et al. The ketone metabolite beta-hydroxybutyrate blocks NLRP3 inflammasome-mediated inflammatory disease. Nat Med. 2015;21(3):263–9.
Neudorf H, Myette-Cote E, Little JP. The impact of acute ingestion of a ketone monoester drink on LPS-stimulated NLRP3 activation in humans with obesity. Nutrients. 2020;12(3):854.
He C, Zhao Y, Jiang X, Liang X, Yin L, Yin Z, et al. Protective effect of Ketone musk on LPS/ATP-induced pyroptosis in J774A.1 cells through suppressing NLRP3/GSDMD pathway. Int Immunopharmacol. 2019;71:328–35.
Wirtz S, Popp V, Kindermann M, Gerlach K, Weigmann B, Fichtner-Feigl S, et al. Chemically induced mouse models of acute and chronic intestinal inflammation. Nat Protoc. 2017;12(7):1295–309.
Tan G, Huang C, Chen J, Zhi F. HMGB1 released from GSDME-mediated pyroptotic epithelial cells participates in the tumorigenesis of colitis-associated colorectal cancer through the ERK1/2 pathway. J Hematol Oncol. 2020;13(1):149.
Tan G, Huang C, Chen J, Chen B, Zhi F. Gasdermin-E-mediated pyroptosis participates in the pathogenesis of Crohn's disease by promoting intestinal inflammation. Cell Rep. 2021;35(11):109265.
Open Targets Platform. Available from: https://platform.opentargets.org. Accessed 16 May 2019.
Huang C, Wang P, Xu X, Zhang Y, Gong Y, Hu W, et al. The ketone body metabolite beta-hydroxybutyrate induces an antidepression-associated ramification of microglia via HDACs inhibition-triggered Akt-small RhoGTPase activation. Glia. 2018;66(2):256–78.
Yu T, Gan S, Zhu Q, Dai D, Li N, Wang H, et al. Modulation of M2 macrophage polarization by the crosstalk between Stat6 and Trim24. Nat Commun. 2019;10(1):4353.
Gordon S, Martinez FO. Alternative activation of macrophages: mechanism and functions. Immunity. 2010;32(5):593–604.
Mantovani A, Biswas SK, Galdiero MR, Sica A, Locati M. Macrophage plasticity and polarization in tissue repair and remodelling. J Pathol. 2013;229(2):176–85.
Wynn TA, Vannella KM. Macrophages in tissue repair, regeneration, and fibrosis. Immunity. 2016;44(3):450–62.
Puchalska P, Crawford PA. Multi-dimensional roles of ketone bodies in fuel metabolism, signaling, and therapeutics. Cell Metab. 2017;25(2):262–84.
Cosin-Roger J, Ortiz-Masia D, Calatayud S, Hernandez C, Esplugues JV, Barrachina MD. The activation of Wnt signaling by a STAT6-dependent macrophage phenotype promotes mucosal repair in murine IBD. Mucosal Immunol. 2016;9(4):986–98.
Arranz A, Doxaki C, Vergadi E, Martinez de la Torre Y, Vaporidi K, Lagoudaki ED, et al. Akt1 and Akt2 protein kinases differentially contribute to macrophage polarization. Proc Natl Acad Sci U S A. 2012;109(24):9517–22.
Hunter MM, Wang A, Parhar KS, Johnston MJ, Van Rooijen N, Beck PL, et al. In vitro-derived alternatively activated macrophages reduce colonic inflammation in mice. Gastroenterology. 2010;138(4):1395–405.
Antonios JK, Yao Z, Li C, Rao AJ, Goodman SB. Macrophage polarization in response to wear particles in vitro. Cell Mol Immunol. 2013;10(6):471–82.
Waqas SFH, Ampem G, Röszer T. Analysis of IL-4/STAT6 signaling in macrophages. Methods Mol Biol. 2019;1966:211–24.
Novak ML, Koh TJ. Macrophage phenotypes during tissue repair. J Leukoc Biol. 2013;93(6):875–81.
Satriano J, Matsufuji S, Murakami Y, Lortie MJ, Schwartz D, Kelly CJ, et al. Agmatine suppresses proliferation by frameshift induction of antizyme and attenuation of cellular polyamine levels. J Biol Chem. 1998;273(25):15313–6.
Lin SL, Li B, Rao S, Yeo EJ, Hudson TE, Nowlin BT, et al. Macrophage Wnt7b is critical for kidney repair and regeneration. Proc Natl Acad Sci U S A. 2010;107(9):4194–9.
Soto-Mota A, Norwitz NG, Clarke K. Why a d-beta-hydroxybutyrate monoester? Biochem Soc Trans. 2020;48(1):51–9.
Bhattacharya K, Matar W, Tolun AA, Devanapalli B, Thompson S, Dalkeith T, et al. The use of sodium DL-3-Hydroxybutyrate in severe acute neuro-metabolic compromise in patients with inherited ketone body synthetic disorders. Orphanet J Rare Dis. 2020;15(1):53.
Park JS, Kim YJ. Anti-aging effect of the ketone metabolite β-hydroxybutyrate in drosophila intestinal stem cells. Int J Mol Sci. 2020;21(10):3497.
Kim JT, Li C, Weiss HL, Zhou Y, Liu C, Wang Q, et al. Regulation of ketogenic enzyme HMGCS2 by Wnt/β-catenin/PPARγ pathway in intestinal cells. Cells. 2019;8(9):1106.
We thank Doctor Huishi Tan from State Key Laboratory of Organ Failure Research, National Clinical Research Center of Kidney Disease, Division of Nephrology, Nanfang Hospital, for the material support and research instruction.
This work was supported by the National Natural Science Foundation of China (No. 81970465; No. 81970492). This work was granted by Guangdong Science and Technology Project (No. 2017B020209003).
Ethics approval and consent to participate
All procedures involving pathological samples collection and usage were according to the guideline of Ethics Committee of Nanfang Hospital of Southern Medical University (approval number: NFEC-2014-40). All participants gave their informed consent. All animal study protocols were approved by Institutional Animal Care and Use Committee at Southern Medical University (approval number: K2019032).
Consent for publication
The authors declare that they have no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Additional file 1: Table S1.
BHB significantly increases the expression of Arg-1, TGFb2, TGFb3, Wnt5a and Wnt10b in IL-4-stimulated BMDMs. Table S2. Demographic characteristics of the study population. Table S3. Primer sequences for real-time PCR. Figure S1. BHB is decreased in the colons of DSS-exposed mice. Figure S2. Exogenous BHB intervention does not affect intestinal epithelial barrier. Figure S3. Exogenous BHB intervention affect intestinal microbiota composition. Figure S4. The protective effect of BHB against colitis is not depend on gut microbiota. Figure S5. BHB alleviates DSS-induced colitis through the STAT6-dependent signaling pathway. Figure S6. BHB promotes STAT6 phosphorylation in DSS-induced colitis. Figure S7. Model of how beta-hydroxybutyrate (BHB) signaling regulates intestinal macrophage M2 polarization in IBD.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Huang, C., Wang, J., Liu, H. et al. Ketone body β-hydroxybutyrate ameliorates colitis by promoting M2 macrophage polarization through the STAT6-dependent signaling pathway. BMC Med 20, 148 (2022). https://doi.org/10.1186/s12916-022-02352-x
- Inflammatory bowel disease
- M2 macrophage
- Tissue repair